Nautilus Biotech: AH Equity Partners Sells 5 Million Shares in Tactical Shift While Retaining Majority Stake
AH Equity Partners Bio II sells 5 M Nautilus shares at $2.35, a calculated gain‑harvest while holding 1.8% stake—an insight into insider strategy and future outlook.
3 minutes to read
